The immunomodulatory effect of probiotics beyond atopy: an update

References

• Burke W, Fesinmeyer M, Reed K, Hampson L, Carlsten C. Family history as a predictor of asthma risk. Am J Prev Med 2003;24:160–169
   PubMed Web of Science ®Google Scholar
• Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259–1260
   PubMed Web of Science ®Google Scholar
• Ouwehand AC. Antiallergic effect of probiotics. J Nutr 2007;137:794S–797S
   PubMed Web of Science ®Google Scholar
• Moore WEC, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 2007;27:961–979
   Google Scholar
• Macpherson AJ, Geuking MB, McCoy KD. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 2005;115:153–162
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Kasper DL. The love–hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 2005;6:849–858
   Web of Science ®Google Scholar
• Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology 2009;128:e523–e531
   PubMed Web of Science ®Google Scholar
• Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361–367
   PubMed Web of Science ®Google Scholar
• Lee J, Mo JH, Shen C, Rucker AN, Raz E. Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol 2007;23:27–31
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Hao L, Medzhitov R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 2006;25:319–329
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Sher A. Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007;7:179–190
   PubMed Web of Science ®Google Scholar
• Cario E. Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2. Gut 2005;54:1182–1193
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685–711
   PubMed Web of Science ®Google Scholar
• Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006;24:677–688
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006;441:235–238
   PubMed Web of Science ®Google Scholar
• Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008;454:350–352
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Napolitani G, Lanzavecchia SF. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942–949
   PubMed Web of Science ®Google Scholar
• Rimoldi M, Chieppa M, Larghi P, Vulcano M, Allavena P, Rescigno M. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 2005;106:2818–2826
   PubMed Web of Science ®Google Scholar
• Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a toll-like receptor 2 pathway. J Allergy Clin Immunol 2006;117:696–702
   PubMed Web of Science ®Google Scholar
• Gad M, Ravn P, Søborg DA, Ouwehand AC, Jensen SS. Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria. FEMS Immunol Med Microbiol 2011;63:93–107
   PubMedGoogle Scholar
• Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol 2008;84:468–476
   PubMed Web of Science ®Google Scholar
• Smits HH, van Beelen AJ, Hessle C, Westland R, de Jong E, Soeteman E, Wold A, et al. Commensal gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol 2004;34:1371–1380
   PubMed Web of Science ®Google Scholar
• Rescigno M. Mucosal immunology and bacterial handling in the intestine. Best Pract Res Clin Gastroenterol 2013;27:17–24
   PubMed Web of Science ®Google Scholar
• Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005;307:254–258
   PubMed Web of Science ®Google Scholar
• Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol 2011;32:256–264
   PubMed Web of Science ®Google Scholar
• Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 2011;108:4607–4614
   PubMed Web of Science ®Google Scholar
• Yin Y, Wang Y, Zhu L, Liu W, Liao N, Jiang M, Zhu B, et al. Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens. ISME J 2013;7:615–621
   PubMed Web of Science ®Google Scholar
• Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, Foschi D, et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009;58:1481–1489
   PubMed Web of Science ®Google Scholar
• Jaensson E, Uronen-Hansson H, Pabst O, Eksteen B, Tian J, Coombes JL, Berg PL, et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008;205:2139–2149
   PubMed Web of Science ®Google Scholar
• Diehl GE, Longman RS, Zhang JX, Breart B, Galan C, Cuesta A, Schwab SR, Littman DR. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 2013;494:116–120
   PubMed Web of Science ®Google Scholar
• Hadis U, Wahl B, Schulz O, Hardtke-Wolenski M, Schippers A, Wagner N, Müller W, et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011;34:237–246
   PubMed Web of Science ®Google Scholar
• Kayama H, Ueda Y, Sawa Y, Jeon SG, Ma JS, Okumura R, Kubo A, et al. Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis. Proc Natl Acad Sci USA 2012;109:5010–5015
   PubMed Web of Science ®Google Scholar
• Schulz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, Pabst O. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 2009;206:3101–3114
   PubMed Web of Science ®Google Scholar
• Medina-Contreras O, Geem D, Laur O, Williams IR, Lira SA, Nusrat A, Parkos CA, Denning TL. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest 2011;121:4787–4795
   PubMed Web of Science ®Google Scholar
• Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005;115:66–75
   PubMed Web of Science ®Google Scholar
• Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR, Stoklasek T, et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer’s patches. Immunity 2006;24:623–632
   PubMedGoogle Scholar
• Iwasaki A, Kelsall BL. Localization of distinct Peyer’s patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000;191:1381–1394
   PubMed Web of Science ®Google Scholar
• Fink LN, Frokiaer H. Dendritic cells from Peyer’s patches and mesenteric lymph nodes differ from spleen dendritic cells in their response to commensal gut bacteria. Scand J Immunol 2008;68:270–279
   PubMed Web of Science ®Google Scholar
• Contractor N, Louten J, Kim L, Biron CA, Kelsall BL. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol 2007;179:2690–2694
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662–1665
   PubMed Web of Science ®Google Scholar
• Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331–341
   PubMed Web of Science ®Google Scholar
• Morelli L, Capurso L. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol 2012;46:S1–S2
   PubMed Web of Science ®Google Scholar
• Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001;32:1567–1576
   PubMed Web of Science ®Google Scholar
• Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;96:490–494
   Google Scholar
• Rautava S, Kalliomaki M, Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: probiotics – a Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol 2005;116:31–37
   PubMed Web of Science ®Google Scholar
• Rook GA, Brunet LR. Old friends for breakfast. Clin Exp Allergy 2005;35:841–842
   PubMed Web of Science ®Google Scholar
• von der Weid T, Bulliard C, Schiffrin EJ. Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol 2001;8:695–701
   PubMedGoogle Scholar
• Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005;115:1260–1267
   PubMed Web of Science ®Google Scholar
• Lammers KM, Brigidi P, Vitali B, Gionchetti P, Rizzello F, Caramelli E, Matteuzzi D, Campieri M. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003;8:165–172
   Google Scholar
• Guarner F. Enteric flora in health and disease. Digestion 2006;73:5–12
   PubMed Web of Science ®Google Scholar
• Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005;54:317–320
   PubMed Web of Science ®Google Scholar
• Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004;112:352–363
   PubMed Web of Science ®Google Scholar
• Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E. The hygiene hypothesis of atopic disease – an extended version. J Pediatr Gastroenterol Nutr 2004;38:378–388
   PubMed Web of Science ®Google Scholar
• Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 2004;72:4996–5003
   PubMed Web of Science ®Google Scholar
• Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 2007;175:561–569
   PubMed Web of Science ®Google Scholar
• Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun 2005;73:30–38
   PubMed Web of Science ®Google Scholar
• Prescott SL, Dunstan JA, Hale J, Breckler L, Lehmann H, Weston S, Richmond P. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy 2005;35:1557–1564
   PubMed Web of Science ®Google Scholar
• Vitaliti G, Cimino C, Coco A, Pratico AD, Lionetti E. The immunopathogenesis of cow's milk protein allergy (CMPA). Ital J Pediatr 2012;23:35
   Google Scholar
• Lara-Villoslada F, Sierra S, Díaz-Ropero MP, Rodríguez JM, Xaus J, Olivares M. Safety assessment of Lactobacillus fermentum CECT5716, a probiotic strain isolated from human milk. J Dairy Res 2009;76:216–221
   PubMed Web of Science ®Google Scholar
• Salazar N, Ruas-Madiedo P, Kolida S, Collins M, Rastall R, Gibson G, de Los Reyes-Gavilán CG. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. Int J Food Microbiol 2009;135:260–267
   PubMed Web of Science ®Google Scholar
• Conover MS, Sloan GP, Love CF, Sukumar N, Deora R. The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin. Mol Microbiol 2010;77:1439–1455
   PubMed Web of Science ®Google Scholar
• Xu CL, Wang YZ, Jin ML, Yang XQ. Preparation, characterization and immunomodulatory activity of selenium-enriched exopolysaccharide produced by bacterium Enterobacter cloacae Z0206. Bioresour Technol 2009;100:2095–2097
   PubMed Web of Science ®Google Scholar
• Alp G, Aslim B. Relationship between the resistance to bile salts and low pH with exopolysaccharide (EPS) production of Bifidobacterium spp. isolated from infants feces and breast milk. Anaerobe 2010;16:101–105
   PubMed Web of Science ®Google Scholar
• Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, Motherway MO, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci 2012;109:2108–2113
   PubMed Web of Science ®Google Scholar
• Weintraub A. Immunology of bacterial polysaccharide antigens. Carbohydr Res 2003;338:2539–2547
   PubMed Web of Science ®Google Scholar
• Buchanan RM, Arulanandam BP, Metzger DW. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. J Immunol 1998;161:5525–5533
   PubMed Web of Science ®Google Scholar
• Moussu H, Van Overtvelt L, Horiot S, Tourdot S, Airouche S, Zuercher A, Holvoet S, et al. Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy. Int Arch Allergy Immunol 2012;158:35–42
   PubMed Web of Science ®Google Scholar
• López P, González-Rodríguez I, Sánchez B, Gueimonde M, Margolles A, Suárez A. Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy. Vaccine 2012;30:825–829
   PubMed Web of Science ®Google Scholar
• Foligné B, Dewulf J, Breton J, Claisse O, Lonvaud-Funel A, Pot B. Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni. Int J Food Microbiol 2010;140:136–145
   PubMed Web of Science ®Google Scholar
• Sepp E, Julge K, Mikelsaar M, Björkstén B. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005;35:1141–1146
   PubMed Web of Science ®Google Scholar
• Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. J Allergy Clin Immunol 2001;107:129
   PubMed Web of Science ®Google Scholar
• Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001;108:144–145
   PubMed Web of Science ®Google Scholar
• Murray CS, Tannock GW, Simon MA, Harmsen HJ, Welling GW, Custovic A, Woodcock A. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy 2005;35:741–745
   PubMed Web of Science ®Google Scholar
• He F, Morita H, Hashimoto H, Kurisaki J-I, Hosoda M, Kurisaki J, Ouwehand AC, et al. Intestinal Bifidobacterium species induce varying cytokine production. J Allergy Clin Immunol 2002;109:1035–1036
   PubMed Web of Science ®Google Scholar
• Morita H, He F, Fuse T, Ouwehand AC, Hashimoto H, Hosoda M, Mizumachi K, Kurisaki J. Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol Immunol 2002;46:293–297
   PubMed Web of Science ®Google Scholar
• He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001;30:43–47
   PubMedGoogle Scholar
• Norin E, Midtvedt T, Björksten B. Development of faecal short-chain fatty acid pattern during the first year of life in Estonian and Swedish infants. Microb Ecol Health Dis 2004;16:8–12
   Google Scholar
• Zeiger RS. Food allergen avoidance in the prevention of food allergy in infants and children. Pediatrics 2003;111:1662–1671
   PubMed Web of Science ®Google Scholar
• Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604–1610
   PubMed Web of Science ®Google Scholar
• Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111:389–395
   PubMed Web of Science ®Google Scholar
• Vitaliti G, Pavone P, Guglielmo F, Falsaperla R. Sublingual immunotherapy in preschool children: an update. Expert Rev Clin Immunol 2013;9:385–390
   PubMed Web of Science ®Google Scholar
• Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004;113:805–820
   PubMed Web of Science ®Google Scholar
• Host A. Cow’s milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects. Pediatr Allergy Immunol 1994;5:1–36
   PubMedGoogle Scholar
• James JM, Sampson HA. Immunologic changes associated with the development of tolerance in children with cow milk allergy. J Pediatr 1992;121:371–377
   PubMed Web of Science ®Google Scholar
• Host A, Halken S, Jacobsen HP, Christensen AE, Herskind AM, Plesner K. Clinical course of cow’s milk protein allergy/intolerance and atopic diseases in childhood. Pediatr Allergy Immunol 2002;13:23–28
   PubMed Web of Science ®Google Scholar
• Strobel S. Neonatal oral tolerance. Ann N Y Acad Sci 1996;778:88–102
   PubMed Web of Science ®Google Scholar
• Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;29:342–346
   PubMed Web of Science ®Google Scholar
• Pessi T, Sutas Y, Marttinen A, Isolauri E. Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics. J Nutr 1998;128:2313–2318
   PubMed Web of Science ®Google Scholar
• Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, Kauffman HF, Duiverman EJ. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006;36:899–906
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, Veereman-Wauters G, De Greef E, Peeters S, Casteels A, Mahler T, Devreker T, Hauser B. Probiotics and prebiotics in prevention and treatment of diseases in infants and children. J Pediatr (Rio J) 2011;87:292–300
   PubMed Web of Science ®Google Scholar
• Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111:389–395
   PubMed Web of Science ®Google Scholar
• Sistek D, Kelly R, Wickens K, Stanley T, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy 2006;36:629–633
   PubMed Web of Science ®Google Scholar
• Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, Vaarala O, Savilahti E. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 2005;115:1254–1259
   PubMed Web of Science ®Google Scholar
• Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005;90:892–897
   PubMed Web of Science ®Google Scholar
• Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004;15:152–158
   PubMed Web of Science ®Google Scholar
• Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179–185
   PubMed Web of Science ®Google Scholar
• Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 2005;16:65–71
   PubMed Web of Science ®Google Scholar
• Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005;60:494–500
   PubMed Web of Science ®Google Scholar
• Berni Canani R, Nocerino R, Terrin G, Coruzzo A, Cosenza L, Leone L, Troncone R. Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial. J Allergy Clin Immunol 2012;129:580–582
   PubMed Web of Science ®Google Scholar
• Ghadimi D, Folster-Holst R, de Vrese M, Winkler P, Heller KJ, Schrezenmeir J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 2008;213:677–692
   PubMed Web of Science ®Google Scholar
• Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow’s milk allergy. J Allergy Clin Immunol 2004;114:131–136
   PubMed Web of Science ®Google Scholar
• Donato KA, Gareau MG, Wang YJ, Sherman PM. Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 2010;156:3288–3297
   PubMed Web of Science ®Google Scholar
• Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009;4:e7056
   PubMed Web of Science ®Google Scholar
• Nagler-Anderson C. Tolerance and immunity in the intestinal immune system. Crit Rev Immunol 2000;20:103–120
   PubMed Web of Science ®Google Scholar
• Newberry RD, Stevenson WF, Lorenz RG. Cycloxynegase-2-dependent arachidonic acid metabolites are essential modulators of the immune response to dietary antigen. Nat Med 1999;5:900–906
   PubMed Web of Science ®Google Scholar
• Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739–1745
   PubMed Web of Science ®Google Scholar
• Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, Folkerts G, et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009;101:S1–S45
   PubMed Web of Science ®Google Scholar
• Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108–114
   PubMed Web of Science ®Google Scholar
• Kuisma J, Mentula S, Jarvinen H, Kahri A, Saxelin M, Farkkila M. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003;17:509–515
   PubMed Web of Science ®Google Scholar
• Gupta P, Andrew H, Kirschner BS, Guandalini S. Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000;31:453–457
   PubMed Web of Science ®Google Scholar
• Schultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC. Lactobacillus GG in inducing and maintaining remission of Crohn’s disease. BMC Gastroenterol 2004;15:4–5
   Google Scholar
• Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut 2002;51:405–409
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:305–309
   PubMed Web of Science ®Google Scholar
• Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, Gigliobianco A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 2004;10:I126–I131
   Web of Science ®Google Scholar
• Zocco MA, dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M, Novi M, et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 2006;23:1567–1574
   PubMed Web of Science ®Google Scholar
• Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, Liu YH, et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004;10:1521–1525
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003;22:56–63
   PubMed Web of Science ®Google Scholar
• Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O’neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005;54:242–249
   PubMed Web of Science ®Google Scholar
• Nowak B, Ciszek-Lenda M, Sróttek M, Gamian A, Kontny E, Górska-Frączek S, Marcinkiewicz J. Lactobacillus rhamnosus exopolysaccharide ameliorates arthritis induced by the systemic injection of collagen and lipopolysaccharide in DBA/1 mice. Arch Immunol Ther Exp (Warsz) 2012;60:211–220
   PubMed Web of Science ®Google Scholar
• So JS, Song MK, Kwon HK, Lee CG, Chae CS, Sahoo A, Jash A, et al. Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis. Life Sci 2011;14(88):358–366
   Google Scholar
• Amdekar S, Singh V, Singh R, Sharma P, Keshav P, Kumar A. Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. J Clin Immunol 2011;31:147–154
   PubMed Web of Science ®Google Scholar
• Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, Ahrens B, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007;37:498–505
   PubMed Web of Science ®Google Scholar
• Hong HJ, Kim E, Cho D, Kim TS. Differential suppression of heat-killed lactobacilli isolated from kimchi, a Korean traditional food, on airway hyper-responsiveness in mice. J Clin Immunol 2010;30:449–458
   PubMed Web of Science ®Google Scholar
• Yu J, Jang SO, Kim BJ, Song YH, Kwon JW, Kang MJ, Choi WA, et al. The effects of Lactobacillus rhamnosus on the prevention of asthma in a murine model. Allergy Asthma Immunol Res 2010;2:199–205
   PubMed Web of Science ®Google Scholar
• Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076–1079
   PubMed Web of Science ®Google Scholar
• Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002;57:243–246
   PubMed Web of Science ®Google Scholar
• Shida K, Takahashi R, Iwadate E, Takamizawa K, Yasui H, Sato T, Habu S, et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 2002;32:563–570
   PubMed Web of Science ®Google Scholar
• Pavone P, Longo MR, Taibi R, Nunnari G, Romano C, Passaniti E, Falsaperla R. Acute asthma in children: treatment in emergency. Eur Rev Med Pharmacol Sci 2011;15:711–716
   PubMed Web of Science ®Google Scholar
• Pavone P, Longo MR, Scalia F, Polosa R, Kira J, Falsaperla R. Recurrent Hopkin’s syndrome: a case report and review of the literature. J Neurol Sci 2010;297:89–91
   PubMed Web of Science ®Google Scholar
• Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002;110:617–623
   PubMed Web of Science ®Google Scholar
• Jang SO, Kim HJ, Kim YJ, Kang MJ, Kwon JW, Seo JH, Kim HY, et al. Asthma prevention by Lactobacillus rhamnosus in a mouse model is associated with CD4(+)CD25(+)FoxP3(+) T Cells. Allergy Asthma Immunol Res 2012;4:150–156
   PubMed Web of Science ®Google Scholar